No, the New York Times did not kill your patient.

One of the more depressing things about getting much more interested in the debate over how we should screen for common cancers, particularly breast and prostate cancer, is my increasing realization of just how little physicians themselves understand about the complexities involved in weighing the value of such tests. It's become increasingly apparent to me that most physicians believe that early detection is always good and that it always saves lives, having little or no conception of lead time or length bias.

Related Keywords

New York ,United States ,American ,Aaron Carroll ,John Schumann ,Stanislaw Burzynski ,George Lombardi ,Fred Hutchinson Cancer Center ,New York Times ,University Of Washington ,Breast Cancer Surveillance Consortium ,United States Preventive Services Task ,Us Preventative Services Task Force ,American Cancer Society ,Killed By The New York ,United States Preventive Services Task Force ,Internal Medicine ,Comparative Effectiveness ,Model Estimates ,Potential Benefits ,Services Task Force ,Screening Mammography ,Breast Density ,Postmenopausal Hormone Therapy ,